How much improvement in pain is considered important by patients with active psoriatic arthritis

被引：0
|
作者：
Mease, PJ
Ganguly, R
Wanke, L
Yu, E
Singh, A
机构：
[1] Seattle Rheumatol Associates, Seattle, WA USA
[2] GHOA, Wyeth Res, Collegeville, MN USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [21] PAIN PHENOTYPING IN PATIENTS WITH PSORIATIC ARTHRITIS AND HAND OSTEOARTHRITIS
    Vela, J.
    Dreyer, L.
    Petersen, K. Kjaer
    Arent-Nielsen, L.
    Kristensen, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 224 - 225
  • [22] The Effect of Tofacitinib on Residual Pain in Patients with Psoriatic Arthritis
    Dougados, Maxime
    van der Heijde, Desiree
    Bingham, Clifton
    Taylor, Peter
    Fallon, Lara
    Woolcott, John
    Brault, Yves
    Wang, Lisy
    Kessouri, Meriem
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] GUSELKUMAB PROVIDES CONSISTENT AND DURABLE PAIN IMPROVEMENT IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF 2 PHASE 3, RANDOMIZED, CONTROLLED CLINICAL TRIALS
    Nash, P.
    Tam, L. S.
    Tsai, W. C.
    Leung, Y. Y.
    Furtner, D.
    Sheng, S.
    Wang, Y.
    Shawi, M.
    Kollmeier, A.
    Sherlock, J.
    Cua, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 839 - 840
  • [24] THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS
    Dougados, M.
    Van der Heijde, D.
    Bingham, C.
    Taylor, P. C.
    Fallon, L.
    Woolcott, J.
    Brault, Y.
    Wang, L.
    Kessouri, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 756 - 757
  • [25] Efficacy of Tofacitinib on Enthesitis in Patients with Active Psoriatic Arthritis
    Mease, Philip
    Orbai, Ana-Maria
    FitzGerald, Oliver
    Bedaiwi, Mohamed
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela
    Helliwell, Philip S.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3774 - 3776
  • [26] Upadacitinib for the treatment of adult patients with active psoriatic arthritis
    Marchesoni, Antonio
    Citriniti, Giorgia
    Girolimetto, Nicolo
    Possemato, Niccolo
    Salvarani, Carlo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (05) : 423 - 434
  • [27] POPULATION PHARMACOKINETICS OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Zhu, Yaowei
    Mendelsohn, Alan
    Pendley, Charles
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1073 - 1073
  • [28] Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis
    Zhu, Y. W.
    Mendelsohn, A.
    Pendley, C.
    Davis, H. M.
    Zhou, H.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (12) : 830 - 846
  • [29] Guselkumab (TREMFYA®) Provides Consistent and Durable Pain Improvement in Patients with Active Psoriatic Arthritis: Results of 2 Phase 3, Randomized, Controlled Clinical Trials
    Nash, Peter
    Tam, Lai-Shan
    Tsai, Wen-Chan
    Leung, Ying-Ying
    Furtner, Daniel
    Sheng, Shihong
    Wang, Yanli
    Shawi, May
    Kollmeier, Alexa
    Sherlock, Jonathan
    Cua, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2769 - 2772
  • [30] The effect of tofacitinib on residual Open pain in patients with rheumatoid arthritis and psoriatic arthritis
    Dougados, Maxime
    Taylor, Peter C.
    Bingham, Clifton O., III
    Fallon, Lara
    Brault, Yves
    Roychoudhury, Satrajit
    Wang, Lisy
    Kessouri, Meriem
    RMD OPEN, 2022, 8 (02):
12345